OLIGONUCLEOTIDES AS PROBES OF RNA AND RIBOZYME STRUCTURE
Project Number5R01GM043501-05
Contact PI/Project LeaderSCHEPARTZ, ALANNA
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
The objective of this proposal is to develop a new method (linked-
oligonucleotide probes) for the analysis of RNA structure in solution. To
do this, the strengths of chemical synthesis and enzymology have been
combined in a technique which is expected to be more effective than either
crosslinking or chemical probes. This approach requires the synthesis of
molecules that contain two short oligonucleotides, covalently linked, by a
flexible tether of defined length. One of the oligonucleotides will be
constructed of normal deoxynucleotides, the other, of 2'-OMe
ribonucleotides. Each will be complementary to a single-stranded region
present in the RNA under investigation. Simultaneous hybridization of both
ends of this molecule to RNA will occur only if the flexible tether that
separates the two oligonucleotides can traverse the complementary sites.
Because of the substrate specificity of RNase H, treatment of the hybrid
with this enzyme will cleave the RNA exclusively at the site of the RNA:DNA
hybrid. Determination of the lengths of the RNA fragments generated will
identify the cleavage site to nucleotide resolution. Through the use of
tethers of varying length, the distance in space between the two
complementary sites on the macromolecule can be defined. Because the
linked-oligonucleotide probes can be synthesized either entirely or
predominantly using automated solid phase methods, this technique will be
more versatile than conventional crosslinking. Because the data can be
interpreted only in terms of tertiary structure, this technique will be
more straightforward than chemical or enzymatic higher-order structural
analysis. This application will focus on the use of this technique to
investigate the structure of native RNA molecules in solution. However,
the methods described can be applied to the study of ribonucleoprotein
structure, as well as RNA:protein and RNA:DNA interactions in solution.
Specific Aims 1 and 2 focus on the development of this technique using
structurally well characterized yeast tRNAphe. In the first of these
Specific Aims, the 2'-OMe pentanucleotide 5'-UmGmGmUmGm, complementary to
the 3'-end of tRNAphe, will be linked by an abasic phosphodiester tether to
tetraoligonucleotides complementary to either the anticodon, D- or T-loops.
By targeting these three loops, we will define a relationship between the
length of the tether and the distance in A units. In Specific Aim 2, the
two oligonucleotides will be linked by a poly (diaminopentane) linker.
Electrostatic effects may enhance the affinity of these probes for RNA,
resulting in superior molecular rulers. In Specific Aim 3, the techniques
developed in Specific Aim 1 and 2 will be applied towards the study of the
three dimensional structure of a catalytic ribozyme. Our goal is to use
this information to determine which residues constitute the enzyme active
site..
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
RNAX ray crystallographyaminoacyl tRNAchemical cleavagecrosslinkenzyme mechanismenzyme structuremacromoleculemessenger RNAmolecular shapenuclear magnetic resonance spectroscopynucleic acid hybridizationnucleic acid probesnucleic acid structureoligonucleotidesphosphodiesterasesprotein foldingribonucleoproteinsribonucleotidesribosomal RNAribozymesyeasts
No Sub Projects information available for 5R01GM043501-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM043501-05
Patents
No Patents information available for 5R01GM043501-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM043501-05
Clinical Studies
No Clinical Studies information available for 5R01GM043501-05
News and More
Related News Releases
No news release information available for 5R01GM043501-05
History
No Historical information available for 5R01GM043501-05
Similar Projects
No Similar Projects information available for 5R01GM043501-05